Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7529914 | 0.85 | HSP90AA1 (0.35) | HSP90AA1 | |
| SCHEMBL26557 | 0.69 | HSP90AA1 (0.42) | HSP90AA1 | |
| SCHEMBL8641178 | 0.69 | HSP90AA1 (0.42) | HSP90AA1 | |
| SCHEMBL1255165 | 0.65 | — | — | |
| SCHEMBL1255163 | 0.65 | — | — | |
| SCHEMBL3172931 | 0.65 | — | — | |
| SCHEMBL7889267 | 0.63 | — | — | |
| SCHEMBL6265004 | 0.62 | HSP90AA1 (0.31) | HSP90AA1 | |
| SCHEMBL782969 | 0.62 | MEN1 (0.37) | HSP90AA1 | |
| SCHEMBL8669795 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9748606-B2 | Additive for electrolyte of lithium battery, electrolyte including the same, and lithium battery using the electrolyte | SAMSUNG SDI CO., LTD. (KR) | 2017-08-29 | — | — | US | disclosed |
| US-20160056503-A1 | ADDITIVE FOR ELECTROLYTE OF LITHIUM BATTERY, ELECTROLYTE INCLUDING THE SAME, AND LITHIUM BATTERY USING THE ELECTROLYTE | SAMSUNG SDI CO., LTD. (KR) | 2016-02-25 | — | — | US | disclosed |
| EP-0617717-B1 | PHOSPHORUS-CONTAINING TRIAZINE COMPOUNDS AND THEIR USE | AKZO NOBEL UK LTD (GB) | 2002-03-13 | — | — | EP | disclosed |
| US-5534573-A | FLAME RETARDANTS | COURTAULDS PLC (GB) | 1996-07-09 | — | — | US | disclosed |
| EP-0617717-A1 | PHOSPHORUS-CONTAINING TRIAZINE COMPOUNDS AND THEIR USE | COURTAULDS PLC (GB) | 1994-10-05 | — | — | EP | disclosed |
| WO-1993012173-A2 | PHOSPHORUS-CONTAINING TRIAZINE COMPOUNDS AND THEIR USE | COURTAULDS PLC (GB) | 1993-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160056503-A1 | ADDITIVE FOR ELECTROLYTE OF LITHIUM BATTERY, ELECTROLYTE INCLUDING THE SAME, AND LITHIUM BATTERY USING THE ELECTROLYTE | LAGE3, NAA15, TES | HSP90AA1 3919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.